Park Sukhee, Park Joohyun, Choi Ji Won, Bang Yu Jeong, Oh Eun Jung, Park Jiyeon, Hong Kwan Young, Sim Woo Seog
Department of Anesthesiology and Pain Medicine, International St. Mary's Hospital, Catholic Kwandong University School of Medicine, Incheon, Korea.
Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Korean J Pain. 2021 Jan 1;34(1):106-113. doi: 10.3344/kjp.2021.34.1.106.
We aimed to investigate the analgesic efficacy of an erector spinae plane block (ESPB) in immediate breast reconstruction (IBR) with a tissue expander.
Adult women undergoing IBR with a tissue expander after mastectomy were randomly assigned to either intravenous patient-controlled analgesia (IV-PCA) alone (group P) or IV-PCA plus ESPB (group E). The primary outcome was the total amount of opioid consumption during 24 hours postoperatively between the two groups. Secondary outcomes were patient satisfaction, pain score at rest and on shoulder movement using numerical rating scale, incidences of postoperative nausea and vomiting (PONV), and a short form of the brief pain inventory (BPI-SF) at 3 and 6 months after surgery between the groups.
Fifty eight patients completed the study. At 24 hours postoperatively, total opioid consumption was significantly less in group E than in group P (285.0 ± 92.0, 95% confidence interval [CI]: 250.1 to 320.0 223.2 ± 83.4, 95% CI: 191.5 to 254.9, = 0.005). Intraoperative and cumulative PCA fentanyl consumption at 3, 6, 9, and 24 hours were also less in group E than in group P ( = 0.004, = 0.048, = 0.020, = 0.036, and < 0.001, respectively). Patient satisfaction was higher in group E (6.9 ± 1.8 7.8 ± 1.4, = 0.042). The incidences of PONV was similar.
The ESPB decreased postoperative opioid consumption and increased patient satisfaction without significant complications after IBR with a tissue expander after mastectomy.
我们旨在研究竖脊肌平面阻滞(ESPB)在使用组织扩张器进行即刻乳房重建(IBR)中的镇痛效果。
成年女性在乳房切除术后使用组织扩张器进行IBR,被随机分配至单纯静脉自控镇痛(IV-PCA)组(P组)或IV-PCA加ESPB组(E组)。主要结局是两组术后24小时内阿片类药物的总消耗量。次要结局包括患者满意度、使用数字评分量表评估的静息和肩部活动时的疼痛评分、术后恶心呕吐(PONV)的发生率以及两组术后3个月和6个月时的简明疼痛量表简表(BPI-SF)。
58例患者完成了研究。术后24小时,E组的阿片类药物总消耗量显著低于P组(285.0±92.0,95%置信区间[CI]:250.1至320.0;223.2±83.4,95%CI:191.5至254.9,P = 0.005)。E组术中及术后3、6、9和24小时累积PCA芬太尼消耗量也低于P组(分别为P = 0.004、P = 0.048、P = 0.020、P = 0.036和P < 0.001)。E组患者满意度更高(6.9±1.8对7.8±1.4,P = 0.042)。PONV的发生率相似。
乳房切除术后使用组织扩张器进行IBR时,ESPB可降低术后阿片类药物消耗量并提高患者满意度,且无明显并发症。